Close Menu

NEW YORK – In preliminary second quarter results released Thursday, BioMérieux reported 11 percent organic revenue growth at constant exchange rates.

For the quarter completed June 30, 2020, total revenues for the Marcy l’Étoile, France-based firm are expected to be €707 million ($800.8 million), an approximately 11 percent increase over €643 million in the prior-year quarter. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.